Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres-Reference-Cited by-同舟云学术

Voxel-based dosimetry with integrated Y-90 PET/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres

Published:2024-08-29 Issue: Volume: Page:
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Demir Burak^ORCID,Soydal Cigdem,Kucuk Nuriye Ozlem,Celebioglu Emre Can,Bilgic Mehmet Sadık,Kuru Oz Digdem,Elhan Atilla Halil,Kir Kemal Metin

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12149-024-01974-w.pdf

Reference34 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

2. Clark AM, Ma B, Taylor DL, Griffith L, Wells A. Liver metastases: Microenvironments and ex-vivo models. Exp Biol Med (Maywood). 2016;241:1639–52. https://doi.org/10.1177/1535370216658144.

3. Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, et al. BCLC strategy for prognosis prediction and treatment recommendation. the 2022 update. J Hepatol. 2022;76:681–93.

4. Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, et al. 2022 EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nuclear Med Mol Imaging. 2022;49:5. https://doi.org/10.1007/s00259-021-05600-z.

5. Doyle PW, Workman CS, Shah N, McGonigle TW, Grice JV, Huang S, et al. Predictive partition dosimetry and outcomes after yttrium-90 resin microsphere radioembolization of colorectal cancer metastatic to the liver: a retrospective analysis. J Vasc Interv Radiol. 2023;34:2138–46.